批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2019/12/16 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/04/19 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/11/16 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/01/15 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/04/04 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/05/30 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/07/14 |
SUPPL-2(补充) |
Approval |
Labeling |
|
|
|
1994/09/05 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1993/10/20 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1993/04/07 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1991/09/23 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1989/05/31 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:CLINDAMYCIN PHOSPHATE 剂型/给药途径:LOTION;TOPICAL 规格:EQ 1% BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
050600 |
001 |
NDA |
CLEOCIN T |
CLINDAMYCIN PHOSPHATE |
LOTION;TOPICAL |
EQ 1% BASE |
Prescription |
Yes |
Yes |
AB |
1989/05/31
|
PFIZER |
065067 |
001 |
ANDA |
CLINDAMYCIN PHOSPHATE |
CLINDAMYCIN PHOSPHATE |
LOTION;TOPICAL |
EQ 1% BASE |
Prescription |
No |
No |
AB |
2002/01/31
|
FOUGERA PHARMS |
214604 |
001 |
ANDA |
CLINDAMYCIN PHOSPHATE |
CLINDAMYCIN PHOSPHATE |
LOTION;TOPICAL |
EQ 1% BASE |
Prescription |
No |
No |
AB |
2021/03/08
|
PADAGIS ISRAEL |
214526 |
001 |
ANDA |
CLINDAMYCIN PHOSPHATE |
CLINDAMYCIN PHOSPHATE |
LOTION;TOPICAL |
EQ 1% BASE |
Prescription |
No |
No |
AB |
2021/06/28
|
TARO |
215607 |
001 |
ANDA |
CLINDAMYCIN PHOSPHATE |
CLINDAMYCIN PHOSPHATE |
LOTION;TOPICAL |
EQ 1% BASE |
Prescription |
No |
No |
AB |
2022/01/18
|
ENCUBE |